Table 4.
Variable | Univariate analysis |
Multivariate analysis |
||||
---|---|---|---|---|---|---|
OR (95% CI) | p value | Estimate | SE | OR (95% CI) | p value | |
Treatment groupa | 1.078 (0.693–1.677) | 0.7393 | ||||
Sexb | 1.039 (0.579–1.866) | 0.8972 | ||||
Age | 0.988 (0.970–1.006) | 0.1756 | ||||
Disease duration | 0.999 (0.996–1.001) | 0.3000 | ||||
SDAI at baseline | 0.977 (0.957–0.997) | 0.0251c | ||||
HAQ score at baseline | 0.662 (0.483–0.907) | 0.0102c | –0.435 | 0.165 | 0.648 (0.469–0.894) | 0.0083d |
OR, odds ratio; CI, confidence interval; SE, standard error; SDAI, simplified disease activity index; HAQ, Health Assessment Questionnaire.
0 = conventional disease-modifying antirheumatic drug (DMARD), 1 = biologic DMARD.
0 = female, 1 = male.
p < 0.05.
p < 0.01.